Registration - In-house Corporation

Novartis Pharmaceuticals Canada Inc. / Christian Macher, Country President & Oncology General Manager Canada

Registration Information
In-house Corporation name: Novartis Pharmaceuticals Canada Inc.
Responsible Officer Name: Christian Macher, Country President & Oncology General Manager Canada 
Responsible Officer Change History
Initial registration start date: 2007-07-13
Registration status: Active
Registration Number: 944053-15599
Associated Communications

Total Number of Communication Reports: 18

Monthly communication reports in the last 6 months: 4

Version 1 of 29 (2007-07-13 to 2008-02-12)

Version 1 of 29 (2007-07-13 to 2008-02-12) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Responsible Officer and Corporation

Corporation: Novartis Pharmaceuticals Canada Inc.
385 Bouchard Blvd.
Dorval, QC  H9S 1A9
Canada
Telephone number: 514-633-7880  Ext.: 3395
Fax number: 514-631-0307  
Responsible officer name and position during the period of this registration: David Meek, President  
Description of activities: Marketing & distribution of pharmaceuticals products.
 
Parent: The corporation is not a subsidiary of any other parent corporations.
Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Corporation

Name: Alain Boisvert
Position title: VP, Health Policy & Market Access
Public offices held: No
 
Name: Shona Kinley
Position title: Director, Health Policy - Atlantic Canada & Federal
Public offices held: Yes
 
Name: Patricia Manzi
Position title: National Director, Health Policy
Public offices held: No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Atlantic Canada Opportunities Agency (ACOA), Fisheries and Oceans Canada (DFO), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), National Defence (DND), Veterans Affairs Canada (VAC)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Industry, Intellectual Property, Science and Technology
 
Subject Matter: Retrospective: Intellectual Property re: Data protection
Subject Matter: Prospective: Develop business relationships and discuss the innovation agenda and other Novartis federal isses as they arise.
 
Details Regarding the Identified Subject Matter
Categories Description
Legislative Proposal Changes to Patent Legislation
Legislative Proposal Other Health Policies including the National Pharmaceutical Strategy, Cross-Border Trade and Data Protection, National Cancer Strategy
Legislative Proposal Patented Medicine Prices Review Board (PMPRB) pricing guidelines




Date Modified: